Streamline Health Solutions, Inc.

  • Market Cap: Micro Cap
  • Industry: Computers - Software & Consulting
  • ISIN: US86323X1063
USD
5.33
0 (-0.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

How big is Streamline Health Solutions, Inc.?

22-Jun-2025

As of Jun 18, Streamline Health Solutions, Inc. has a market capitalization of $22.50 million, with net sales of $17.90 million and a net profit of -$10.16 million over the latest four quarters. The company's balance sheet shows shareholder's funds of $12.28 million and total assets of $35.58 million.

As of Jun 18, Streamline Health Solutions, Inc. has a market capitalization of 22.50 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 17.90 million for the latest four quarters. During the same period, it experienced a net profit of -10.16 million.<BR><BR>As of Jan 25, the company's balance sheet shows shareholder's funds of 12.28 million and total assets amounting to 35.58 million.

Read More

What does Streamline Health Solutions, Inc. do?

22-Jun-2025

Streamline Health Solutions, Inc. provides healthcare information technology solutions and operates in the micro-cap market. As of January 2025, it reported net sales of $5 million and a net loss of $2 million, with a market cap of $22.5 million.

Overview: <BR>Streamline Health Solutions, Inc. is engaged in providing healthcare information technology solutions within the Computers - Software & Consulting industry, operating in the micro-cap market.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 5 Million (Quarterly Results - Jan 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Jan 2025) <BR>Market-cap: USD 22.50 Million (Micro Cap)<BR><BR>Key Metrics: <BR>Debt Equity: 1.13 <BR>Return on Equity: -81.18% <BR>Price to Book: 2.04<BR><BR>Contact Details: <BR>Address: 11800 Amber Park Drive - Suite 125, ALPHARETTA GA: 30009 <BR>Tel: 1 404 4462052 <BR>Website: https://www.streamlinehealth.net/

Read More

Should I buy, sell or hold Streamline Health Solutions, Inc.?

22-Jun-2025

Who are in the management team of Streamline Health Solutions, Inc.?

22-Jun-2025

As of March 2022, the management team of Streamline Health Solutions, Inc. includes Jonathan Phillips (Independent Chairman), Wyche Green (President and CEO), Justin Ferayorni, David Sides, Kenan Lucas, and Judith Starkey (all Directors). They oversee the company's strategic direction and operations.

As of March 2022, the management team of Streamline Health Solutions, Inc. includes the following individuals:<BR><BR>- Mr. Jonathan Phillips, Independent Chairman of the Board<BR>- Mr. Wyche Green, President, Chief Executive Officer, and Director<BR>- Mr. Justin Ferayorni, Director<BR>- Mr. David Sides, Director<BR>- Mr. Kenan Lucas, Independent Director<BR>- Ms. Judith Starkey, Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and overseeing its operations.

Read More

Is Streamline Health Solutions, Inc. technically bullish or bearish?

20-Sep-2025

As of July 8, 2025, Streamline Health Solutions, Inc. shows a bullish technical trend with mixed signals from various indicators, having returned 41.76% year-to-date but underperformed over the past year with a -17.29% return compared to the S&P 500's 17.14%.

As of 8 July 2025, the technical trend for Streamline Health Solutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The weekly RSI is bearish, but the monthly RSI is bullish, indicating mixed signals. The daily moving averages are bullish, supporting the overall bullish stance. The KST is bullish on a weekly basis and mildly bullish monthly, while the Bollinger Bands show a bullish trend in both weekly and monthly time frames. However, the weekly Dow Theory indicates a bearish stance, and the OBV shows no trend weekly but is bullish monthly.<BR><BR>In terms of performance, the stock has returned 41.76% year-to-date, significantly outperforming the S&P 500's 12.22% return in the same period. However, over the past year, the stock has underperformed, with a return of -17.29% compared to the S&P 500's 17.14%. Overall, the current technical stance is bullish, but the strength is mixed due to conflicting indicators.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -2.90% and Operating profit at -243.90% over the last 5 years

 
2

The company has declared Negative results for the last 4 consecutive quarters

3

Risky - Negative EBITDA

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Computers - Software & Consulting

stock-summary
Market cap

USD 23 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1,484.68%

stock-summary
Debt Equity

1.13

stock-summary
Return on Equity

-81.18%

stock-summary
Price to Book

2.06

Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Apr 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
108.63%
0%
108.63%
6 Months
45.63%
0%
45.63%
1 Year
-17.29%
0%
-17.29%
2 Years
367.54%
0%
367.54%
3 Years
-78.72%
0%
-78.72%
4 Years
-76.78%
0%
-76.78%
5 Years
329.84%
0%
329.84%

Streamline Health Solutions, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.16%
EBIT Growth (5y)
-209.11%
EBIT to Interest (avg)
-7.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.13
Sales to Capital Employed (avg)
0.69
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
26.12%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.83
EV to EBIT
-4.59
EV to EBITDA
-13.80
EV to Capital Employed
1.44
EV to Sales
1.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-31.32%
ROE (Latest)
-75.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bullish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Bearish
No Trend
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Apr 2025 is 11.63% vs -18.87% in Apr 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Apr 2025 is 40.74% vs 6.90% in Apr 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Apr'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.80",
          "val2": "4.30",
          "chgp": "11.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.10",
          "val2": "-0.40",
          "chgp": "75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.50",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.80",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.60",
          "val2": "-2.70",
          "chgp": "40.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-228.90%",
          "val2": "-344.30%",
          "chgp": "11.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jan'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jan 2025 is -20.80% vs -9.24% in Jan 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jan 2025 is 45.45% vs -64.04% in Jan 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jan'25",
        "Jan'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.90",
          "val2": "22.60",
          "chgp": "-20.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.90",
          "val2": "-3.30",
          "chgp": "12.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "1.10",
          "chgp": "81.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.90",
          "val2": "-9.60",
          "chgp": "90.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.20",
          "val2": "-18.70",
          "chgp": "45.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-406.10%",
          "val2": "-359.00%",
          "chgp": "-4.71%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Apr'25 - YoYstock-summary
Apr'25
Apr'24
Change(%)
Net Sales
4.80
4.30
11.63%
Operating Profit (PBDIT) excl Other Income
-0.10
-0.40
75.00%
Interest
0.50
0.50
Exceptional Items
0.00
-0.80
100.00%
Consolidate Net Profit
-1.60
-2.70
40.74%
Operating Profit Margin (Excl OI)
-228.90%
-344.30%
11.54%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Apr 2025 is 11.63% vs -18.87% in Apr 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Apr 2025 is 40.74% vs 6.90% in Apr 2024

Annual Results Snapshot (Consolidated) - Jan'25stock-summary
Jan'25
Jan'24
Change(%)
Net Sales
17.90
22.60
-20.80%
Operating Profit (PBDIT) excl Other Income
-2.90
-3.30
12.12%
Interest
2.00
1.10
81.82%
Exceptional Items
-0.90
-9.60
90.62%
Consolidate Net Profit
-10.20
-18.70
45.45%
Operating Profit Margin (Excl OI)
-406.10%
-359.00%
-4.71%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jan 2025 is -20.80% vs -9.24% in Jan 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jan 2025 is 45.45% vs -64.04% in Jan 2024

stock-summaryCompany CV
About Streamline Health Solutions, Inc. stock-summary
stock-summary
Streamline Health Solutions, Inc.
Computers - Software & Consulting
Streamline Health Solutions, Inc. is engaged in providing healthcare information technology through the licensing of its Electronic Health Information Management, Patient Financial, Coding and Clinical Documentation Improvement (CDI), and other Workflow software applications, and the use of such applications by software as a service. The Company also provides implementation and consulting services to complement its software solutions. The Company provides computer software-based solutions through its Looking Glass platform. The Company sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships. The Company's software and services allow hospitals and integrated healthcare delivery systems in the United States and Canada to capture, store, manage, route, retrieve and process patient clinical, financial and other healthcare provider information.
Company Coordinates stock-summary
Company Details
11800 Amber Park Drive - Suite 125 , ALPHARETTA GA : 30009
Registrar Details